&nbsp;

Immunotherapy Medications: What You Need to Know

Nov 2019

Document

Immunotherapy Medications: What You Need to Know (French)

Nov 2019

Document

IMPACT_Newsletter_First_Issue

Nov 2019

Document

IMPACT_Newsletter_Second_Edition

Nov 2019

Document

IMPACT_Newsletter_Third_Edition

Nov 2019

Document

IMPACT_Newsletter_Fourth_Edition

Nov 2019

Document

IMPACT_Newsletter_Fifth_Edition

Nov 2019

Regimen

LENV

Cancer Type:

Genitourinary,

Renal cell / Kidney

, Collapse Show fewer tags

Intent: Palliative

Drugs Used:

lenvatinib (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Sep 2020

Regimen

LIPOCYTADAUN(CONS)

Cancer Type:

Hematologic

Intent: Curative, Palliative

Funding:

New Drug Funding Program

Liposomal Daunorubicin and Liposomal Cytarabine (Outpatient) - Previously Untreated Acute Myeloid Leukemia

liposomal DAUNOrubicin / liposomal cytarabine

Drugs Used:

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Dec 2023

Regimen

LENV

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

Exceptional Access Program

lenvatinib - For the treatment of unresectable advanced hepatocellular carcinoma according to clinical criteria